Insider Ledger
Nuvectis Pharma, Inc. (NVCT) insider buying and SEC filings
Nuvectis Pharma, Inc. · CIK 1875558
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$1.1M
Insiders who bought
4
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 30, 2026 | Open-market purchase | Marlio Charles Mosseri (10% owner) bought 50,000 shares indirectly (by entity) at about $18.32 ($916K) in an open-market purchase. Holdings by entity up 2% to 3,186,576 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 1, 2026 |
| Jun 30, 2026 | Other purchase | Ron Bentsur (CEO and Director) bought 12,500 Common Stock at $20.00 ($250K) in a public offering. Holdings up <1% to 3,688,424 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 1, 2026 |
| Nov 5, 2025 | Purchase (code P) | Ron Bentsur (CEO and Director) bought 5,000 shares at $5.72 ($29K), reported as a purchase (code P). Holdings up <1% to 3,525,924 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 6, 2025 |
| Nov 5, 2025 | Open-market purchase | Juan Sanchez (Director) bought 13,000 shares at about $5.79 ($75K) in an open-market purchase. Holdings up 20% to 78,150 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 6, 2025 |
| Nov 5, 2025 | Open-market purchase | Matthew L. Kaplan (Director) bought 11,000 shares at about $5.84 ($64K) in an open-market purchase. Holdings up 10% to 124,760 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 6, 2025 |
9 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
4 insiders bought in 30 days
$1.1M in purchases since Oct 27, 2025 · Purchases traded Oct 27, 2025 to Nov 5, 2025 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Marlio Charles Mosseri (10% owner) | $957K | Oct 27, 2025 | SEC filing |
| Matthew L. Kaplan (Director) | $64K | Nov 5, 2025 | SEC filing |
| Juan Sanchez (Director) | $75K | Nov 5, 2025 | SEC filing |
| Ron Bentsur (CEO) | $29K | Nov 5, 2025 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow NVCT in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.